| Safety and Immune Response to Vicriviroc in Combination Regimens in HIV-Infected ART Experienced Children and Adolescents (NCT00766597) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-08-01 |
| CSL H1N1 Influenza Vaccine Administered at Two Dose Levels in Adult and Elderly Populations (NCT00943488) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-08-01 |
| Sanofi H1N1 + TIV - Adults and Elderly (NCT00943878) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-08-01 |
| Sanofi Pasteur, TIV + H1N1, Pediatric Population (NCT00943202) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-08-01 |
| Longitudinal Study of the Human Intestinal Microbiome (NCT00832286) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-07-23 |
| Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia (NCT00867269) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-07-13 |
| Early Immune Responses to Vaccination - A Substudy to HVTN 205 (NCT00908323) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-07-01 |
| Immune Development in Pediatric Transplantation (IMPACT) (NCT00951353) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-07-01 |
| Safety of and Immune Response to DEN4 Vaccine Component Candidate for Dengue Virus (NCT00919178) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-07-01 |
| Pharmacokinetic Study of Oseltamivir and Intravenous Zanamivir in Healthy Adults (NCT00921726) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-07-01 |
| Pathogenesis of Physical Induced Urticarial Syndromes (NCT00887939) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-06-17 |
| Immune Response to Varicella-Zoster Vaccination and Infection (NCT00921999) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-06-15 |
| Establishing Fibroblast-Derived Cell Lines From Skin Biopsies of Patients With Immunodeficiency or Immunodysregulation Disorders (NCT00895271) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-06-10 |
| Viral Triggers in Pediatric Lung Transplantation (NCT00891865) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-06-01 |
| Influenza Vaccine in Pregnant Women (NCT00905125) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-06-01 |
| A Randomized Double-Blind Control-Comparison Crossover Trial of Oral Glutamine to Suppress Frequently Recurrent Herpes Labialis (NCT00913692) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-06-01 |
| High Dose IMVAMUNE® in Vaccinia-Naive Individuals (NCT00879762) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-05-29 |
| Host Factors in Invasive and Recurrent Staphylococcus Aureus Infection (NCT00911430) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-05-28 |
| Safety and Effectiveness of HIV-1 DNA Plasmid Vaccine and HIV-1 Recombinant Adenoviral Vector Vaccine in HIV-Uninfected, Circumcised Men and Male-to-Female (MTF) Transgender Persons Who Have Sex With Men (NCT00865566) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-05-01 |
| Safety of Immunosuppression Minimization in Children and Adolescents After Kidney Transplantation (NCT00768729) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-05-01 |
| Combination Pain Therapy in HIV Neuropathy (NCT00863057) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-05-01 |
| Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy (NCT00851786) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-04-29 |
| A Randomized, Double-Blind, Placebo-Controlled Study of Omalizumab for Idiopathic Anaphylaxis (NCT00890162) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-04-27 |
| Phase I Study of the Safety and Immunogenicity of BSAM-2/Alhydrogel +CPG 7909, an Asexual Blood Stage Vaccine for Plasmodium Falciparum Malaria in Adults in the US and Mali (NCT00889616) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-04-23 |
| Dose Escalation Study of SQ109 in Healthy Adult Volunteers (NCT00866190) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-04-01 |
| Strategies Using Off-Patent Antibiotics for Methicillin Resistant S. Aureus "STOP MRSA" (NCT00729937) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-04-01 |
| Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus (NCT00730028) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-04-01 |
| Normal Blood, Bone Marrow and Buccal Mucosa Protocol (NCT00806364) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-03-26 |
| Estivation of Malaria Vector Mosquitoes in the Sahelian Region of Mali (NCT00863408) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-03-03 |
| VRC 307: A Double-Blind, Randomized Phase I Study of the Safety and Immunogenicity of a Prime-Boost Schedule of the Investigational DNA Trivalent Influenza Vaccine, VRC-FLUDNA047-00-VP, Followed by the 2008/2009 Seasonal Influenza Trivalent Inactivat... (NCT00858611) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-03-03 |
| Malaria Challenge With NF54 Strain (NCT00744133) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-03-01 |
| Anti-TNF Agents for the Treatment of Rheumatoid Arthritis (NCT00837434) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-03-01 |
| Safety and Immune Response to a Recombinant Adenovirus HIV-1 Vaccine in Healthy Adults (NCT00695877) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-02-08 |
| Safety and Immune Response to Preventive HIV Immunization With Adenovirus Serotype 5 or 35 Vector (NCT00801697) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-02-01 |
| The Underlying Mechanisms For S. Aureus Infection And Colonization Of Skin in People With Atopic Dermatitis With And Without Eczema Herpeticum (MRSA) (NCT00822276) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-02-01 |
| Interleukin-7 (CYT107) Treatment of Idiopathic CD4 Lymphocytopenia: Expansion of CD4 T Cells (ICICLE) (NCT00839436) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-02-01 |
| Safety of Acidform Lubricant in HIV-Uninfected Women (NCT00850837) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-02-01 |
| Pertussis Vaccine in Healthy Pregnant Women (NCT00707148) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-01-01 |
| Biomarker-based Cockroach Sublingual Immunotherapy Study (BioCSI) (NCT00829985) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-01-01 |
| Safety and Immune Response to Two Doses of rDEN2/4delta30 Dengue Vaccine (NCT00920517) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-01-01 |
| Modeling Study to Predict Progression of Anal Cancer Pre-cursor Lesions in HIV (NCT01709448) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-01-01 |
| Safety of and Immune Response to a Prime-Boost Vaccine Regimen in HIV-Uninfected Vaccine-Naive Adults (NCT00820846) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-01-01 |
| Measurement of Anti-TB Drugs in Lung Tissue From Patients Having Surgery to Treat Tuberculosis (NCT00816426) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-12-29 |
| BCG Vaccination Delivered Intradermally, Orally and by Combined Routes (NCT00396370) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-12-02 |
| Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3-3'Ddelta30) in Healthy Adults (NCT00712803) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-12-01 |
| Combined Kidney and Bone Marrow Transplantation to Prevent Kidney Transplant Rejection (NCT00801632) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-12-01 |
| Analysis of Response of Subjects With Atopic Dermatitis or Psoriasis to Oral Vitamin D3 (NCT00789880) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-12-01 |
| Blood Markers of Inflammation, Blood Clotting and Blood Vessel Function in HIV-infected Adults (NCT00776412) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-11-20 |
| Clinical and Immunologic Monitoring of Patients With Known or Suspected HIV Infection (NCT00789009) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-11-20 |
| Analysis of HIV-1 Replication During Antiretroviral Therapy (NCT00767312) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-11-17 |
| Cause of Unexplained Anaphylaxis (NCT00719719) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-11-05 |
| Safety of and Immune Response to Two HIV Vaccines: SAAVI DNA-C2 Boosted With SAAVIMVA-C, in HIV-Negative Adults (NCT00574600) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-11-01 |
| Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA) (NCT00796705) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-11-01 |
| H5N1 (Clade 2) Vaccination of Adults and Elderly (NCT00680069) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-11-01 |
| Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis (NCT00774852) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-11-01 |
| Vitamin D3 in Systemic Lupus Erythematosus (NCT00710021) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-11-01 |
| Hepatitis B and HIV Co-Infection in Patients in Uganda (NCT00782158) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-10-27 |
| Vaccine for Prevention of Bird Flu (NCT00776711) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-10-16 |
| Immune Parameters in the Cord Blood of Newborns Exposed to Malaria in the Womb (NCT00772642) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-10-08 |
| LEA29Y (Belatacept) Emory Edmonton Protocol (NCT00468403) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-10-01 |
| Safety and Pharmacokinetic Study of Fixed Dose Combination of Zidovudine, Lamivudine, and Nevirapine in HIV-Infected Children in Thailand (NCT00672412) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-10-01 |
| Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System (NCT00794352) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-10-01 |
| Safety, Reactogenicity and Immunogenicity of MVA in Hematopoietic Stem Cell Transplant (HSCT) Subjects (NCT00565929) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-09-01 |
| Safety of and Immune Response to Recombinant Live-Attenuated Influenza H6N1 Virus Vaccine Vaccine (NCT00734175) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-09-01 |
| H5N1 Priming and Boosting Strategies (NCT00703053) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-09-01 |
| Malaria Vaccine for Children in Mali (NCT00740090) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-08-11 |
| RELIVE Informed Consent Study (NCT01742234) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-08-01 |
| Immune Response to Yellow Fever Vaccination in Adults With Atopic Dermatitis (NCT00723489) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-08-01 |
| Pioglitazone to Treat Fatty Liver in Patients With HIV and Hepatitis C Infections (NCT00742326) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-08-01 |
| Study of Milk Allergy and Tolerance in Children (NCT00778258) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-08-01 |
| Bacterial Vaginosis Home Screening to Prevent STDs (NCT00667368) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-07-28 |
| Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation (NCT00789308) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-07-11 |
| Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation After Kidney Transplant (NCT00790439) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-07-01 |
| Linezolid to Treat Extensively-Drug Resistant Tuberculosis (NCT00727844) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-07-01 |
| Phase I Study of HIV Adenoviral Vector Vaccine in Healthy Subjects Using Needle or Biojector Injection (NCT00709605) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-06-25 |
| Response to Standard HIV Treatment in Bamako, Mali (NCT00703404) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-06-18 |
| Safety and Immunogenicity of Peru-15-pCTB in Healthy Adult Subjects (NCT00654108) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-06-02 |
| Short-Term vs. Long-Term Valganciclovir Therapy for Symptomatic Congenital CMV Infections (NCT00466817) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-06-01 |
| Adherence and Acceptability to and Blood Levels of Tenofovir Gel and Tablets in HIV Uninfected Women (NCT00592124) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-06-01 |
| Genomics of Chronic Renal Allograft Rejection (The GoCAR Study) (NCT00611702) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-06-01 |
| Protective Immunity to Human Cholera in Bangladesh (NCT00349999) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-06-01 |
| Study of Viral Load Decay Rates in HIV Infected Participants Starting Treatment With Raltegravir (RAL) and Emtricitabine/Tenofovir Disoproxil Fumarate (TDF) (NCT00660972) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-05-01 |
| Drug Treatment Combined With Drug and Risk Reduction Counseling to Prevent of HIV Infection and Death Among Injection Drug Users (NCT00270257) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-05-01 |
| Intensive Viral Dynamics Substudy of A5248 (NCT00852618) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-05-01 |
| Innate and Acquired Resistance to Plasmodium Falciparum Malaria in Mali (NCT00669084) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-04-21 |
| Malaria Studies in Cambodia (NCT00663546) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-03-24 |
| Poly-ICLC to Prevent Respiratory Viral Infections A Safety Study (NCT00646152) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-03-24 |
| Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4delta30) in Healthy Adults (NCT00537147) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-03-01 |
| Safety, Reactogenicity, and Immunogenicity of Inactivated Influenza A/H7/N7 Vaccine in Healthy Adults (NCT00546585) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-03-01 |
| Safety of and Immune Response to Recombinant Live-Attenuated Parainfluenza Type 1 Virus Vaccine (NCT00641017) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-03-01 |
| Etanercept for the Treatment of Lupus Nephritis (NCT00447265) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-02-01 |
| Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women (NCT00604175) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-02-01 |
| Enteroaggregative E.Coli (EAEC) (NCT00362869) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-02-01 |
| Safety of and Immune Response to an Adenoviral HIV-1 Vaccine in Healthy Adults (NCT00618605) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-02-01 |
| H9 Priming Study in Healthy Adults (NCT00617331) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-02-01 |
| Ebola and Marburg Virus Vaccines (NCT00605514) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-01-25 |
| Dyskinesia, Heterotaxy and Congenital Heart Disease (NCT00608556) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-01-25 |
| Influenza in People With Normal and Weakened Immune Systems (NCT00533182) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-01-03 |
| HIV Screening in the Emergency Department Setting (NCT00667186) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-01-01 |
| Optimizing Treatment for Treatment-Experienced, HIV-Infected People (NCT00537394) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-01-01 |